scispace - formally typeset
T

Tsuyoshi Ohkuni

Researcher at Sapporo Medical University

Publications -  18
Citations -  571

Tsuyoshi Ohkuni is an academic researcher from Sapporo Medical University. The author has contributed to research in topics: Tight junction & Barrier function. The author has an hindex of 11, co-authored 16 publications receiving 499 citations.

Papers
More filters
Journal ArticleDOI

A nuclear factor-κB signaling pathway via protein kinase C δ regulates replication of respiratory syncytial virus in polarized normal human nasal epithelial cells

TL;DR: It is found that the replication of RSV and the epithelial cell responses including induction of tight junctions were regulated via a protein kinase C δ/hypoxia-inducible factor-1α/nuclear factor-κβ pathway, and the control of this pathway may be useful in therapy for RSV-induced respiratory pathogenesis.
Journal ArticleDOI

c‐Jun N‐terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells

TL;DR: It is suggested that JNK may be involved in the regulation of tricellular tight junctions including TRIC expression and the barrier function during normal remodeling of epithelial cells, and prevent disruption of the epithelial barrier in inflammation and other disorders in pancreatic duct epithel cells.
Journal ArticleDOI

PPARγ agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells

TL;DR: It is suggested that PPAR gamma agonists upregulate the barrier function of tight junctions of human nasal epithelial cells via a PKC signaling pathway and could be novel drugs for protection against inhaled substances and pathogens in the airway epithelium ofhuman nasal mucosa.
Journal ArticleDOI

Poly(I:C) reduces expression of JAM-A and induces secretion of IL-8 and TNF-α via distinct NF-κB pathways in human nasal epithelial cells

TL;DR: The control of TLR3-mediated signaling pathways in HNECs may be important not only in infection by viral dsRNA but also in autoimmune diseases caused by endogenous ds RNA released from necrotic cells.